|
Income Statement for
Nile Therapeutics Inc.
(NLTX)
|
|
|
|
|
|
|
| Income
[+]
|
in Thousands of Dollars |
|
|
| Operating Revenue |
1,354 |
- |
- |
- |
101 |
| Total Revenue |
1,354 |
- |
- |
- |
101 |
| Adjustments to Revenue |
N/A |
- |
- |
- |
- |
| Cost of Revenue |
- |
(13) |
(160) |
(113) |
(27) |
| Cost of Sales With Depreciation |
- |
- |
- |
- |
- |
| Gross Margin |
1,354 |
13 |
160 |
113 |
128 |
| Gross Operating Profit |
1,354 |
13 |
160 |
113 |
128 |
|
| Selling/General/Admin Expense |
(2,117) |
(2,213) |
(3,417) |
(3,922) |
(4,478) |
| Research & Development |
(4,137) |
(4,081) |
(4,467) |
(9,478) |
(5,124) |
| Advertising |
- |
- |
- |
- |
- |
| EBITDA (Operating Income Before Depreciation) |
- |
(6,281) |
(7,724) |
(13,287) |
(9,473) |
| Depreciation & Amortization |
- |
(13) |
(160) |
(113) |
(27) |
| Depreciation, Unreconciled |
- |
- |
- |
- |
- |
| Amortization |
- |
- |
- |
- |
- |
| Amortization of Intangibles |
- |
- |
- |
- |
- |
| Operating Income |
(4,892) |
(6,294) |
(7,884) |
(13,400) |
(9,500) |
| Operating Profit After Depreciation |
(4,892) |
(6,294) |
(7,884) |
(13,400) |
(9,500) |
| Interest Income |
6 |
20 |
47 |
333 |
- |
| Earnings from Equity Interest |
- |
- |
- |
- |
288 |
| Other Income, Net |
8 |
242 |
(36) |
(64) |
- |
| Income, Acquired in Process R&D |
- |
- |
- |
- |
- |
| Income, Restructuring and M&A |
- |
- |
- |
- |
- |
| Other Special Charges |
- |
- |
- |
- |
- |
| Total Income Before Interest Expense (EBIT) |
- |
(6,031) |
(7,872) |
(13,131) |
(9,213) |
| Interest Expense |
- |
- |
- |
(0) |
(1,090) |
| Income Before Tax |
- |
(6,031) |
(7,872) |
(13,132) |
(10,303) |
| Income Taxes |
- |
- |
- |
- |
- |
| Minority Interest |
- |
- |
- |
- |
- |
| Preferred Securities of Subsidiary Trust |
- |
- |
- |
- |
- |
| Other Special Charges |
- |
- |
- |
- |
- |
| Net Income from Continuing Operations |
(4,885) |
(6,031) |
(7,872) |
(13,132) |
(10,303) |
| Net Income from Discontinued Operations |
- |
- |
- |
- |
- |
| Net Income from Total Operations |
(4,885) |
(6,031) |
(7,872) |
(13,132) |
(10,303) |
|
| Normalized Income |
(4,885) |
(6,031) |
(7,872) |
(13,132) |
(10,303) |
| Extraordinary Income/Loss |
- |
- |
- |
- |
- |
| Special Income/Charges |
- |
- |
- |
- |
- |
| Income from Cum. Effect of Acct Change |
- |
- |
- |
- |
- |
| Income from Tax Loss Carryforward |
- |
- |
- |
- |
- |
| Net Income Available for Common |
(4,885) |
(6,031) |
(7,872) |
(13,132) |
(10,303) |
| Other Gains |
- |
- |
- |
- |
- |
| Total Net Income |
(4,885) |
(6,031) |
(7,872) |
(13,132) |
(10,303) |
| Net Income Available for Common |
(4,885) |
(6,031) |
(7,872) |
(13,132) |
(10,303) |
|
| Results
[+]
|
in Dollars (Preferred Dividends in Thousands) |
|
|
| Dividends Paid Per Share |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Preferred Dividends |
- |
- |
- |
- |
- |
| Basic EPS from Continuing Operations |
-0.13 |
-0.19 |
-0.31 |
-0.54 |
-0.61 |
| Basic EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Extraordinary Income Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Basic EPS from Total Net Income |
-0.13 |
-0.19 |
-0.31 |
-0.54 |
-0.61 |
| Basic Normalized Net Income per Share |
-0.13 |
-0.19 |
-0.31 |
-0.54 |
-0.61 |
| Basic EPS from Total Operations |
-0.13 |
-0.19 |
-0.31 |
-0.54 |
-0.61 |
|
| Diluted EPS from Continuing Operations |
-0.13 |
-0.19 |
-0.31 |
-0.54 |
-0.61 |
| Diluted EPS from Discontinued Operations |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Extraordinary Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Cumulative Effect of Accounting Change |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Tax Loss Carryforward |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Other Gains/Losses |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Diluted EPS from Total Net Income |
-0.13 |
-0.19 |
-0.31 |
-0.54 |
-0.61 |
| Diluted Normalized Net Income per Share |
-0.13 |
-0.19 |
-0.31 |
-0.54 |
-0.61 |
| Excise Tax |
- |
- |
- |
- |
- |
| Diluted EPS from Total Operations |
-0.13 |
-0.19 |
-0.31 |
-0.54 |
-0.61 |
|
|
|
